Two groups of doctors presented clinical data on the use of Kerecis Omega3-rich fish skin at this week’s American College of Foot & Ankle Surgeons annual meeting in San Antonio, Texas. The first group included Drs. Jonathan Hook and Gurleen Cheema from Mercy Hospital & Medical Center in Chicago, IL and Drs. Randal Lepow, Jason Bahng, Angelica Emeakoroha, Alan Simon and Tomas Trevino from the St. Joseph Medical Center in Houston, TX.
From the town of Ísafjörður in northwest Iceland, Kerecis develops, manufactures, and distributes patented fish-skin medical devices that support soft tissue regeneration in the body, with regulatory approvals in the United States, Europe, and beyond.
